Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Novo Nordisk CEO Talks Obesity Drugs, Philanthropy | Bloomberg Talks
Posted
June 6, 2024
Views
107
Likes
2
Engagement
1.87%
June 6, 2024
107
2
1.87%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
24:04Now PlayingNovo Nordisk is Europe’s most valuable company with booming demand for its blockbuster diabetes and obesity drugs, Ozempic and Wegovy. They’re revolutionizing the weight loss drug industry, with some analysts predicting it could be worth up to $150 billion a year. Elon Musk, Sharon Osborne and Chelsea Handler have all publicly talked about taking Ozempic or Wegovy, and they've had further backing from Oprah Winfrey. The success has also propelled the company's philanthropic foundation to become the world's largest, with more than double the assets of the Gates Foundation. But it's not without controversy, including possible side effects and high prices, with US Senator Bernie Sanders pressing the company to lower the cost of Wegovy. On the latest episode of Leaders with Lacqua, Francine Lacqua travels to the firm’s headquarters in Copenhagen, Denmark. She speaks to chief executive, Lars Fruergaard Jørgensen.
See omnystudio.com/listener () for privacy information.
Bloomberg Talks curates top interviews from around Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment. On Bloomberg Talks, we round up interviews with Fortune 500 CEOs, government officials, well-known investors and business leaders.
Listen to more Bloomberg Talks
Subscribe to Bloomberg Podcasts
#Bloomberg #Podcast
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
